Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Cash from Investing Activities (2024 - 2025)

Zenas BioPharma (ZBIO) has 2 years of Cash from Investing Activities data on record, last reported at $40.0 million in Q3 2025.

  • For Q3 2025, Cash from Investing Activities rose 249.64% year-over-year to $40.0 million; the TTM value through Sep 2025 reached -$162.3 million, changed N/A, while the annual FY2024 figure was -$30.6 million, 179617.65% down from the prior year.
  • Cash from Investing Activities reached $40.0 million in Q3 2025 per ZBIO's latest filing, up from -$112.3 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $40.0 million in Q3 2025 and bottomed at -$112.3 million in Q2 2025.